Reaching the Last 20% (the Pamoja Kwa Afya Study)
Reaching the Last 20%: a Targeted HIV Self-test Secondary Distribution Intervention to Engage High-risk Men in Kenya
1 other identifier
interventional
5,000
1 country
1
Brief Summary
This cluster randomized controlled trial will test whether the provision of multiple oral fluid-based HIV self-test kits to women who sell sex (WSS) to secondarily distribute to their male partners who purchase sex can promote uptake of HIV service use by male partners. The study will recruit adult women who report exchanging sex for compensation in Kisumu and Siaya counties in Western Kenya. In clusters randomized to the intervention, WSS will be given multiple HIV self-tests and counseled to distribute them to men who purchase sex (MPS). Self-test kits will contain instructions for use and tailored information on clinic location and hours within the cluster, and pilot-tested messaging on the benefits of antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP). In control clusters, standard of care HIV services will continue to be available. To objectively assess impacts of the intervention on post-HIVST linkage outcomes, the investigators will monitor use of HIV services by men at HIV clinics in both study arms on a monthly basis. Our goal will be to determine whether confirmatory testing (primary outcome), case diagnoses, ART initiation, and PrEP initiation by men in intervention clusters are higher than in control clusters. Mixed methods research will be utilized to conduct a process evaluation to assess mechanisms that may have impacted intervention effectiveness, pathways for linkage among MPS, and support for men's linkage to HIV services under a secondary distribution model. Cost-effectiveness analyses will also be undertaken.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hiv
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2023
CompletedFirst Posted
Study publicly available on registry
May 31, 2023
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 29, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 7, 2026
March 18, 2025
March 1, 2025
2.2 years
May 18, 2023
March 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HIV testing
The count of adult men from each cluster who completed an HIV test at the clinic within the intervention versus control period.
3 months
Secondary Outcomes (2)
HIV case diagnoses
3 months
ART and PrEP initiation
3 months
Study Arms (1)
HIV self-test secondary distribution
EXPERIMENTALThe investigators will provide women who sell sex enrolled in the study with multiple World Health Organization (WHO) and Kenya-approved oral fluid-based HIV self-test kits. Participants will be counseled to secondarily distribute self-tests to their male transactional sex partners. Self-test kits will contain instructions for use and tailored information on clinic locations and hours within the cluster, the benefits of early ART use, and the availability and benefits of PrEP.
Interventions
Oral fluid-based HIV self-test kits for secondary distribution
Salient information for men included with the self-test kit on clinic location and hours within their cluster, and pilot-tested messaging on the importance of early ART initiation, and the availability and benefits of PrEP
Eligibility Criteria
You may qualify if:
- Female
- Age ≥18 years
- Reports exchanging sex for compensation with ≥2 men in the past month
- Engages in sex for compensation in the intervention cluster catchment area
- Willing to participate in a brief questionnaire 6 weeks after enrollment
- Plan to remain in the area of study recruitment for the next 8 weeks
You may not qualify if:
- Unwilling or unable to provide informed consent for participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sue Napieralalead
- Impact Research & Development Organizationcollaborator
- University of Pennsylvaniacollaborator
- University of North Carolina, Chapel Hillcollaborator
Study Sites (1)
Impact Research and Development Organization (IRDO)
Kisumu, Kenya
Related Publications (4)
Thirumurthy H, Masters SH, Mavedzenge SN, Maman S, Omanga E, Agot K. Promoting male partner HIV testing and safer sexual decision making through secondary distribution of self-tests by HIV-negative female sex workers and women receiving antenatal and post-partum care in Kenya: a cohort study. Lancet HIV. 2016 Jun;3(6):e266-74. doi: 10.1016/S2352-3018(16)00041-2. Epub 2016 Apr 8.
PMID: 27240789BACKGROUNDLynch M, Pentecost BL, Littler WA, Stockley RA. The distribution of antibodies to streptokinase. Postgrad Med J. 1996 May;72(847):290-2. doi: 10.1136/pgmj.72.847.290.
PMID: 8761502BACKGROUNDNapierala S, Bair EF, Marcus N, Ochwal P, Maman S, Agot K, Thirumurthy H. Male partner testing and sexual behaviour following provision of multiple HIV self-tests to Kenyan women at higher risk of HIV infection in a cluster randomized trial. J Int AIDS Soc. 2020 Jun;23 Suppl 2(Suppl 2):e25515. doi: 10.1002/jia2.25515.
PMID: 32589354BACKGROUNDMasters SH, Agot K, Obonyo B, Napierala Mavedzenge S, Maman S, Thirumurthy H. Promoting Partner Testing and Couples Testing through Secondary Distribution of HIV Self-Tests: A Randomized Clinical Trial. PLoS Med. 2016 Nov 8;13(11):e1002166. doi: 10.1371/journal.pmed.1002166. eCollection 2016 Nov.
PMID: 27824882BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Sue Napierala, PhD, MPH
RTI International
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
May 18, 2023
First Posted
May 31, 2023
Study Start
March 1, 2024
Primary Completion (Estimated)
May 29, 2026
Study Completion (Estimated)
August 7, 2026
Last Updated
March 18, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share